Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making waves in the industry with its innovative product pipeline and strong market performance.

Will AMD maintain its earnings streak as AI competition heats up? Markets price in 8% stock move as chipmaker eyes $7.53B ...

Is CyberArk overvalued despite recent growth from Venafi acquisition? Find out why it's rated as a Hold in this financial ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

And in a note published Sunday, Goldman strategists led by David Kostin have set out the equity market implications of Trump's latest move. One way stocks may come under pressure is that large tariffs ...

Lam Research's Q2-2025 earnings beat expectations, with strong revenue and EPS growth. Read why I remain neutral on LRCX ...

ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...

Stock analysts at Roth Capital dropped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a ...

Apple reported its latest quarterly earnings results Thursday, revealing all-time record-breaking sales for its ...

Corporate America just kicked off a new quarterly earnings season. The company has become a worthy competitor to Nvidia in ...

Advanced Micro Devices' Q4 performance is likely to have been hurt by weakness in the Embedded and Gaming segments, offset by ...